In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curvesULTRASONICSIF4.12012-01-0126PREAI
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatmentsINVESTIGATIONAL NEW DRUGSIF2.72010-10-0610PREAI
Contrast Ultrasonography: Necessity of Linear Data Processing for the Quantification of Tumor VascularizationULTRASCHALL IN DER MEDIZINIF2.92010-06-2449PREAI
Acoustic characterization of a new trisacryl contrast agent. Part I: In vitro studyULTRASONICSIF4.12008-03-015PREAI
Acoustic characterization of a new trisacryl contrast agent. Part II: Flow phantom study and in vivo quantificationULTRASONICSIF4.12008-03-011PREAI
Early quantitative evaluation of a tumor vasculature disruptive agent AVE8062 using dynamic contrast-enhanced ultrasonographyINVESTIGATIVE RADIOLOGYIF82008-02-0175PREAI
In vitro echogenicity characterization of poly[lactide-coglycolide] (PLGA) microparticles and preliminary in vivo ultrasound enhancement study for ultrasound contrast agent applicationINVESTIGATIVE RADIOLOGYIF82005-08-0118PREAI
Validation of a new method for quantifying in vivo murine tumor necrosis by sonographyINVESTIGATIVE RADIOLOGYIF82004-06-0126PREAI
A new ultrasound principle for characterizing erythrocyte aggregation - In vitro reproducibility and validationINVESTIGATIVE RADIOLOGYIF82002-08-0110PREAI
Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivoINVESTIGATIVE RADIOLOGYIF82001-01-01105OAAI
New hemodynamic approach to angiogenesis -: Color and pulsed Doppler ultrasonographyINVESTIGATIVE RADIOLOGYIF81999-03-0147PRE